Skip to content
Search

Latest Stories

NPA: Hub and spoke impact assessment proves justification for pharmacy cut was hollow

The National Pharmacy Association (NPA) has called for an immediate reconsideration on pharmacy funding as the official impact assessment of hub and spoke dispensing reveals that only limited extent of savings may be possible under the model.

The total savings to the pharmacy sector’s operational costs are calculated to be approximately £1 million by 2024, when the current contractual framework comes to an end. This compares to well over a billion pounds withheld from the sector over the contract period (2019-24), due to flat funding below inflation.


The NPA claims that the real-terms funding cuts since 2019, and indeed earlier cuts, were based in part on government promises of cost savings through hub and spoke.

Nick Kaye, NPA vice-chair, said:“The current 5-year funding deal promised clinical service developments, but with a downward ratchet on funding predicated on dispensing efficiencies. The promise was that independents would have the same opportunity as large multiples to secure the benefits of outsourcing elements of dispensing to a hub. Now it is clear that hundreds of independents won’t be in a position to benefit at all and that the savings for others will be miniscule compared to the money taken out of the global sum.

“These official figures confirm that there is an enormous gap between money taken out and any potential savings from hub and spoke.

Kaye called for an "honest conversation about efficiencies - a conversation that reflects the reality for independents struggling to survive."

“The government should go back to the drawing board on pharmacy funding, now that one of the central arguments for cuts has been exposed as completely hollow,” he added.

According to NPA calculation, had the global sum increased in line with inflation (including future projections) throughout the five years of the deal to 2024, more than £1.2bn in funding would have flowed to community pharmacy by 2024.

The Department of Health and Social Care impact assessment accompanied the launch of a consultation on legislative changes needed to permit hub and spoke between different legal entities. The consultation ends on 8 June.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less